← SynDRA
DIMERCAPROL
SynDRA canonical compound SYN0011898 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Mechanism of action | chelating agent |
|---|
| Indication | metal toxicity |
|---|
| Disease area | neurology/psychiatry |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- NR1I2
- ALDH1A1
- GMNN
- TDP1
- SMAD3
- LMNA
- KAT2A
- HTT
- HSD17B10
- GLS
- ALOX15B
- FEN1
- EHMT2
- CYP3A4
- CYP2D6
- CYP2C9
- CYP2C19
- CYP1A2
- VDR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ANDR
- CP2C9
- CP2D6
- CP3A7
- GCR
Drug classes
- Metal Chelating Activity
- Metal Chelator
- Chelating Agents
- Sequestering Agents
- chelating agent
ATC classes
- V03A · ALL OTHER THERAPEUTIC PRODUCTS
Cross-references
Synonyms
- BAL
- dithioglycerine
- dicaptol
- 1-propanol, 2,3-dimercapto
- 2,3,-dimercapto-1-propanol
- 2,3-dithiopropan-1-ol
- 2,3-dithiopropanol
- Antoxol
- Dicaptol
- Dimercaprolum
- Dimersol
- Panobal
- Sulfactin
- NSC-39515
- NSC-4646
- Anti-lewisite
- B.a.l.
- Bal
- 1-Propanol, 2,3-dimercapto
- dimercaprol (usp monograph)
- Dithioglycerol
- 0CPP32S55X
- 3-Hydroxy-1,2-propanedithiol
- dimercaprol (ep monograph)
- Dithioglycerine
- 1,2-Dimercapto-3-propanol
- NSC 39515
- 2,3 Dimercaptopropanol
- NSC 4646
- 2,3-Dithiopropanol
- 1,2-Dithioglycerol
- 2,3 -dimercapto-1-propanol
- British Anti Lewisite
- dimercaptopropanol
- British antilewisite
- Usaf me-1
- Dimercaprol propanol
- 2,3-Dimercaptol-1-propanol
Look up DIMERCAPROL in the interactive SynDRA portal →